Pilot program to reimburse patients for hemp-derived products could be undermined by ban passed by CongressThe Centers for Medicare and Medicaid Services recently started a new pilot to reimburse patients for hemp-der...
See morePilot program to reimburse patients for hemp-derived products could be undermined by ban passed by Congress
The Centers for Medicare and Medicaid Services recently started a new pilot to reimburse patients for hemp-derived products – like CBD – but a hemp ban that Congress passed in November could derail the program.
The new program will make certain Medicare and Medicaid recipients eligible for reimbursement for up to $500 worth of hemp products each year and is intended in part to evaluate whether these products could reduce their other health related costs.
Continue reading...
Pilot program to reimburse patients for hemp-derived products could be undermined by ban passed by CongressThe Centers for Medicare and Medicaid Services recently started a new pilot to reimburse patients for hemp-der...
See more